In several U.S. states, Blue Cross/Blue Shield and other insurers have dropped or are considering dropping coverage of hyaluronic acid injection—or viscosupplementation—for patients with knee osteoarthritis. The decision appears to be based on guidelines published by the American Academy of Orthopaedic Surgeons in 2013, which at that time specified that research had not found hyaluronic…

EULAR & ACR Define Rheumatic & Musculoskeletal Disease for Laymen
Understanding rheumatic and musculoskeletal diseases (RMDs) is an understandably tall order for the lay public, what with the huge number of conditions and the complex—and often little understood—processes involved. Now, a working group of the European League Against Rheumatism (EULAR) and the ACR has set out to try to correct this problem with a definition…

Rheumatologists in U.S. on J-1 Visas Face Challenges After Fellowship
I am an alien rheumatologist. Are you? One in five rheumatology fellows is considered an alien. Under the Code of Federal Regulations Title 22 Chapter I Subchapter G Part 62 Subpart B Section 62.27, an alien physician is a foreign national who is a graduate of a school of medicine who comes to the U.S….

The ACR’s Experts on Call Program Connects Journalists with Experts
Rheumatological diseases can be complex, so how can those within the specialty help ensure information about rheumatology shared by the media is accurate? Cue the ACR/ARHP Experts on Call program, which is designed to connect rheumatology health professionals with journalists looking for subject matter experts. Experts on Call is managed by the ACR’s Public Relations…

The Past & Future of Rheumatology Professionals: ACR/ARHP works to address the challenges we face
The ACR and the ARHP have a long, rich history of collaboration, spanning close to 25 years together. Our predecessors saw the value of an interprofessional team and having an organization that brings together a vast number of constituencies. The result was these two organizations coming together in 1994 when the ARHP became a division…
What Is RheumPAC?
RheumPAC is the ACR/ARHP’s nonpartisan political action committee (PAC) that works to elect and support pro-rheumatology candidates. It is the only PAC dedicated to the interests of the rheumatology profession. RheumPAC was created 10 years ago with the mission of electing and supporting federal lawmakers who understand and are in a position to support the…

Strategies for Striking Work–Life Balance
Making time to advance your career and enjoy family life is no easy task. One busy rheumatologist, educator and mom shares her strategies for success…
Join Us for an Advanced Rheumatology Coding & Practice Management Summit in Chicago
Before the ACR/ARHP Annual Meeting gets started in Chicago in October, the ACR’s pre-meeting practice management and coding courses offer an intensive educational opportunity. The Oct. 19–20 sessions, ACR Coding Course: Unlock the Mysteries of Advanced Coding for Rheumatology and Practice Management: Putting the Pieces Together—Winning Strategies for Rheumatology Practices, are the industry’s premier events…
ACR’s 2018 Advocates for Arthritis & Advocacy 101 Program
On Sept. 23–25, the ACR will once again hold its annual Advocates for Arthritis fly-in event in Washington, D.C. Held in conjunction with the ACR’s Advocacy 101 course, the fly-in is a great way for members and their patients to learn about issues important to the practice of rheumatology and have the opportunity to actively…
ACR Responds to Drug Pricing Proposals
Responding to the Trump administration’s drug pricing proposals, the ACR released a set of principles it hopes will help guide any drug policy changes.1 The principles underscore what is critically needed for rheumatologists to provide the best and safest care to their patients, many of whom require ongoing treatment for chronic conditions. “The ACR has…
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 151
- Next Page »